Evidence map›Paper›PMID 36868256›Full record

ArticleThe lancet. Diabetes & endocrinology2023

Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study.

Lynne E Wagenknecht, Jean M Lawrence, Scott Isom, Elizabeth T Jensen, Dana Dabelea, Angela D Liese, Lawrence M Dolan, Amy S Shah, Anna Bellatorre, Katherine Sauder and 6 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06089070 (Feasibility of the FreeStyle Libre Continuous Glucose Monitoring System in Youth With Type 2 Diabetes), which is not on this map. Cited by 152 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 3 pooled it
67.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06089070 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Feasibility of the FreeStyle Libre Continuous Glucose Monitoring System in Youth With Type 2 Diabetes (FREE CGM)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2024 to 2027Enrolled20ConditionsType 2 DiabetesArmsFreeStyle Libre Continuous Glucose Monitor System
3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 3 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Positive affect predicts enhanced quality of life and glycemic outcomes in adolescents with type 1 diabetes.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2026
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Well, How Did We Get Here? The Current State of Pediatric Endocrinology.Journal of pediatrics. Clinical practice · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Diabetes Technology in the School Setting for Preschool-Aged Children.Journal of diabetes science and technology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Twenty-five years of pediatric type 1 diabetes in Serbia: Trends in age at diagnosis, seasonal variation, and the proportion of diabetic ketoacidosis before, during, and after the COVID-19 pandemic.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

Lynne E WagenknechtDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Electronic address: lynne.wagenknecht@wakehealth.edu.
Jean M LawrenceDivision of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Scott IsomDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Elizabeth T JensenDivision of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Dana DabeleaLifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Angela D LieseDepartment of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Lawrence M DolanDepartment of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Amy S ShahDepartment of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Anna BellatorreLifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Katherine SauderLifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Santica MarcovinaMedpace Reference Laboratories, Cincinnati, OH, USA.
Kristi ReynoldsDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Catherine PihokerDepartment of Pediatrics, University of Washington, Seattle, WA, USA.
Giuseppina ImperatoreDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jasmin DiversDivision of Health Services Research, Department of Foundations of Medicine, New York University Long Island School of Medicine, Mineola, NY, USA.
SEARCH for Diabetes in Youth study
University of Colorado Anschutz Medical Campus · USUniversity of Cincinnati Medical Center · USWake Forest University · USCenters for Disease Control and Prevention · USKaiser Permanente · USMedpace (United States) · USNational Institutes of Health · USNew York University · USUniversity of South Carolina · USUniversity of Washington · US

Funding

Population-based Diabetes Youth RegistryU18DP006131 · DP · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2015 to 2019
$3.8M
SEARCH for Diabetes in Youth Registry Study, Phase 4: Carolina Center (Component A)U18DP006138 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAYER-DAVIS, ELIZABETH J · 2015 to 2019
$1.9M
Population-based diabetes in youth registry. SEARCH For Diabetes in Youth, Phase 4, California SiteU18DP006133 · DP · KAISER FOUNDATION RESEARCH INSTITUTE · PI REYNOLDS, KRISTI · 2015 to 2019
$1.9M
The SEARCH for Diabetes in Youth Registry StudyU18DP006139 · DP · UNIVERSITY OF COLORADO DENVER · PI DABELEA, DANA · 2015 to 2019
$1.9M
SEARCH for Diabetes in Youth Registry Study, Phase 4: Washington CenterU18DP006136 · DP · SEATTLE CHILDREN'S HOSPITAL · PI PIHOKER, CATHERINE · 2015 to 2019
$1.9M
SEARCH for Diabetes in Youth Registry Study, Phase 4: Ohio CenterU18DP006134 · DP · CINCINNATI CHILDRENS HOSP MED CTR · PI DOLAN, LAWRENCE M · 2015 to 2019
$1.8M
ACL HHS U18DP006131ACL HHS U18DP006133ACL HHS U18DP006134ACL HHS U18DP006136ACL HHS U18DP006138ACL HHS U18DP006139NCCDPHP CDC HHS U18 DP006131NCCDPHP CDC HHS U18 DP006133NCCDPHP CDC HHS U18 DP006134NCCDPHP CDC HHS U18 DP006136NCCDPHP CDC HHS U18 DP006138NCCDPHP CDC HHS U18 DP006139
6 · The paper itself

Abstract

backgroundThe incidence of diabetes is increasing in children and young people. We aimed to describe the incidence of type 1 and type 2 diabetes in children and young people aged younger than 20 years over a 17-year period.

methodsThe SEARCH for Diabetes in Youth study identified children and young people aged 0-19 years with a physician diagnosis of type 1 or type 2 diabetes at five centres in the USA between 2002 and 2018. Eligible participants included non-military and non-institutionalised individuals who resided in one of the study areas at the time of diagnosis. The number of children and young people at risk of diabetes was obtained from the census or health plan member counts. Generalised autoregressive moving average models were used to examine trends, and data are presented as incidence of type 1 diabetes per 100 000 children and young people younger than 20 years and incidence of type 2 diabetes per 100 000 children and young people aged between 10 years and younger than 20 years across categories of age, sex, race or ethnicity, geographical region, and month or season of diagnosis.

findingsWe identified 18 169 children and young people aged 0-19 years with type 1 diabetes in 85 million person-years and 5293 children and young people aged 10-19 years with type 2 diabetes in 44 million person-years. In 2017-18, the annual incidence of type 1 diabetes was 22·2 per 100 000 and that of type 2 diabetes was 17·9 per 100 000. The model for trend captured both a linear effect and a moving-average effect, with a significant increasing (annual) linear effect for both type 1 diabetes (2·02% [95% CI 1·54-2·49]) and type 2 diabetes (5·31% [4·46-6·17]). Children and young people from racial and ethnic minority groups such as non-Hispanic Black and Hispanic children and young people had greater increases in incidence for both types of diabetes. Peak age at diagnosis was 10 years (95% CI 8-11) for type 1 diabetes and 16 years (16-17) for type 2 diabetes. Season was significant for type 1 diabetes (p=0·0062) and type 2 diabetes (p=0·0006), with a January peak in diagnoses of type 1 diabetes and an August peak in diagnoses of type 2 diabetes.

interpretationThe increasing incidence of type 1 and type 2 diabetes in children and young people in the USA will result in an expanding population of young adults at risk of developing early complications of diabetes whose health-care needs will exceed those of their peers. Findings regarding age and season of diagnosis will inform focused prevention efforts.

fundingUS Centers for Disease Control and Prevention and US National Institutes of Health.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdolescentChildEthnicityHumansIncidenceInfantMinority GroupsUnited StatesYoung Adult

Identifiers

PMID36868256
PMCPMC10091237
OpenAlexW4322603974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.